Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Boyce

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Human Vaccines & Immunotherapeutics|September 24, 2013
Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcomeGary Dubin, Jean-François Toussaint, Jean-Pol Cassart, et al.
Frontiers in Medicine|November 29, 2023
Regulatory agilities impacting review timelines for Pfizer/BioNTech's BNT162b2 mRNA COVID-19 vaccine: a retrospective studyPrisha Patel, Judith C Macdonald, Jayanthi Boobalan, et al.
Clinical and Translational Science|April 9, 2022
A vision for integrated publicly available information on regulated medical productsKhyati Roberts, Roopal Thakkar, Lina Aljuburi, et al.
Therapeutic Innovation & Regulatory Science|December 5, 2025
A Call To Action: Developing an Agile Global Regulatory Affairs Workforce for the FutureLina AlJuburi, Nicole Mahoney, Eddie Reilly, et al.
Nature Reviews. Drug Discovery|June 25, 2025
Generative AI: a generation-defining shift for biopharma regulatory affairsJon Williams, Donna Boyce, Graziella Collu, et al.
Nature Reviews. Drug Discovery|March 6, 2025
Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspectiveAndrew S Robertson, Nahid Latif, Imein Bousnina, et al.
Nature Reviews. Drug Discovery|February 2, 2026
Accelerating the drug regulatory process through a federated cloud ecosystemAndrew S Robertson, Nahid Latif, Raymond C Votzmeyer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|September 24, 2013
Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcomeGary Dubin, Jean-François Toussaint, Jean-Pol Cassart, et al.
Frontiers in Medicine|November 29, 2023
Regulatory agilities impacting review timelines for Pfizer/BioNTech's BNT162b2 mRNA COVID-19 vaccine: a retrospective studyPrisha Patel, Judith C Macdonald, Jayanthi Boobalan, et al.
Clinical and Translational Science|April 9, 2022
A vision for integrated publicly available information on regulated medical productsKhyati Roberts, Roopal Thakkar, Lina Aljuburi, et al.
Therapeutic Innovation & Regulatory Science|December 5, 2025
A Call To Action: Developing an Agile Global Regulatory Affairs Workforce for the FutureLina AlJuburi, Nicole Mahoney, Eddie Reilly, et al.
Nature Reviews. Drug Discovery|June 25, 2025
Generative AI: a generation-defining shift for biopharma regulatory affairsJon Williams, Donna Boyce, Graziella Collu, et al.
Nature Reviews. Drug Discovery|March 6, 2025
Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspectiveAndrew S Robertson, Nahid Latif, Imein Bousnina, et al.
Nature Reviews. Drug Discovery|February 2, 2026
Accelerating the drug regulatory process through a federated cloud ecosystemAndrew S Robertson, Nahid Latif, Raymond C Votzmeyer, et al.
Pageof 1